DOXEPIN
- Product NDC
- 59651-845
- 11-digit product format
- 596510845
- Labeler code
- 59651
- Product ID
- 59651-845_29b3bf98-2c57-4d87-b5eb-5232e46dc639
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOXEPIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA216041
- Marketing category
- ANDA
- Marketing start
- 2025-07-12
- Substance
- DOXEPIN HYDROCHLORIDE
- Active strength
- 6 mg/1
- Pharmacologic classes
- Tricyclic Antidepressant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DOXEPIN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXEPIN HYDROCHLORIDE | 6 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3U9A0FE9N5 |
| Rxcui | 966787, 966793 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-845-30 | DOXEPIN | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 59651-845-30 | 59651084530 | 30 TABLET in 1 BOTTLE (59651-845-30) | 30 tablet | 2025-07-12 | No | No | Current |